<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T00:27:38Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/12990" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/12990</identifier><datestamp>2025-10-24T10:17:32Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024)</dc:title>
   <dc:creator>Arregui, Marta</dc:creator>
   <dc:creator>Carrasco, Irene</dc:creator>
   <dc:creator>Serrano, Cesar</dc:creator>
   <dc:creator>HINDI, NADIA</dc:creator>
   <dc:creator>Martinez-Trufero, Javier</dc:creator>
   <dc:creator>Martinez-Garcia, Jeronimo</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Serrano C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Arregui M] Servicio de Oncología Médica, Hospital General, Universitario Gregorio Marañón, Madrid, Spain. [Carrasco I] Servicio de Oncología Médica Hospital, Universitario Virgen del Rocío, Seville, Spain. [Hindi N] Servicio de Oncología Médica Fundación Jiménez Díaz, Madrid, Spain. [Martínez Trufero J] Servicio de Oncología Médica Hospital Universitario Miguel Servet, Saragossa, Spain. [Martínez García J] Servicio de Oncología Médica Hospital, Universitario Virgen de La Arrixaca, Murcia, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Sarcoma</dc:subject>
   <dc:subject>Tumors de parts toves - Tractament</dc:subject>
   <dc:subject>Tumors de parts toves - Diagnòstic</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/therapy</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms</dc:subject>
   <dc:subject>Other subheadings::Other subheadings::/diagnosis</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de los tejidos blandos</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/terapia</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de los tejidos blandos</dc:subject>
   <dc:subject>Otros calificadores::Otros calificadores::/diagnóstico</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma</dc:subject>
   <dc:description>Rare cancer; Sarcoma; Soft-tissue sarcoma</dc:description>
   <dc:description>Cáncer raro; Sarcoma; Sarcoma de tejidos blandos</dc:description>
   <dc:description>Càncer rar; Sarcoma; Sarcoma de teixits tous</dc:description>
   <dc:description>Soft-tissue sarcomas are rare, diverse malignant tumors of mesenchymal origin, requiring diagnosis and treatment by a specialized multidisciplinary team. Initial assessment includes radiology and biopsy, followed by wide surgical resection with clear margins for localized cases. Radiotherapy is recommended for large, deep, high-grade tumors or after incomplete resection, while perioperative chemotherapy may be considered for high-risk cases. In oligometastatic disease, combining local and systemic therapies is an option. Anthracycline-based chemotherapy is the first-line treatment in advanced disease, though other drugs show efficacy in certain subtypes. Given the limited options, enrolling in clinical trials is advised for patients needing further treatment.</dc:description>
   <dc:date>2025-04-25T09:46:42Z</dc:date>
   <dc:date>2025-04-25T09:46:42Z</dc:date>
   <dc:date>2025-04</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Serrano C, Arregui M, Carrasco I, Hindi N, Martínez-Trufero J, Martínez-García J, et al. SEOM-GEIS Spanish clinical guidelines for the management of soft‑tissue sarcomas (2024). Clin Transl Oncol. 2025 Apr;27:1460-71.</dc:identifier>
   <dc:identifier>1699-3055</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/12990</dc:identifier>
   <dc:identifier>10.1007/s12094-024-03842-5</dc:identifier>
   <dc:identifier>39918719</dc:identifier>
   <dc:identifier>001415600400001</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/12990</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Clinical and Translational Oncology;27</dc:relation>
   <dc:relation>https://doi.org/10.1007/s12094-024-03842-5</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Springer</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>